Anavex Life Sciences Corp. (AVXL)

5.21
0.05 0.95
NASDAQ
Prev Close 5.26
Open 5.23
Day Low/High 5.12 / 5.35
52 Wk Low/High 2.50 / 14.84
Volume 486.32K
Exchange NASDAQ
Shares Outstanding 41.07B
Market Cap 216.05M
Div & Yield N.A. (N.A)

Latest News

Noble Capital Markets Initiates Research Coverage On Anavex Life Sciences Corp. (AVXL)

Noble Capital Markets Initiates Research Coverage On Anavex Life Sciences Corp. (AVXL)

Noble Capital Markets, a leading small-cap focused investment firm, announces the initiation of research coverage of Anavex Life Sciences.

What Adam Feuerstein Got Right and Wrong About Biotech Stocks in 2016

What Adam Feuerstein Got Right and Wrong About Biotech Stocks in 2016

TheStreet's biotech columnist offers his own report card on biotech stocks.

Interesting AVXL Put And Call Options For February 2017

Interesting AVXL Put And Call Options For February 2017

Investors in Anavex Life Sciences Corp saw new options begin trading this week, for the February 2017 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AVXL options chain for the new February 2017 contracts and identified one put and one call contract of particular interest.

Biotechs Bolstered on 21st Century Cures Passage

Biotechs Bolstered on 21st Century Cures Passage

Biotechs were trading at high volumes Thursday morning on news that the Senate has passed the 21st Century Cures Act.

Biotech Stock Mailbag: Looking for an Investable Idea in Alzheimer's Minefield

Biotech Stock Mailbag: Looking for an Investable Idea in Alzheimer's Minefield

TheStreet's Adam Feuerstein answers reader questions about biotech stocks.

Gold, Utilities, Bonds Post Gains

I stopped out of Lantheus Holdings for a small loss and bought Baozun near $15.

Anavex Life Sciences Novel Sigma-1 / Sigma-2 Ligand Shows Encouraging Results As An Analgesic In Animal Models Of Neuropathic And Visceral Pain

Anavex Life Sciences Novel Sigma-1 / Sigma-2 Ligand Shows Encouraging Results As An Analgesic In Animal Models Of Neuropathic And Visceral Pain

Preclinical Data for ANAVEX 1066 Presented at Society for Neuroscience Annual Meeting

Short Interest In Anavex Life Sciences Increases 18.6%

Short Interest In Anavex Life Sciences Increases 18.6%

The most recent short interest data has been released for the 10/14/2016 settlement date, which shows a 883,721 share increase in total short interest for Anavex Life Sciences Corp , to 5,641,528, an increase of 18.57% since 09/30/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

5 Stocks Under $10 Poised for Big Breakouts

These under-$10 stocks are within range of triggering breakout trades. Here's how to trade them from here.

4 Big-Volume Stocks to Add to Your Buy List -- Plus 3 to Avoid

4 Big-Volume Stocks to Add to Your Buy List -- Plus 3 to Avoid

Here's a technical look at how to trade some of the most active stocks on the market right now.

Anavex (AVXL) Stock Soars on Parkinson's Drug Success

Anavex (AVXL) Stock Soars on Parkinson's Drug Success

Anavex (AVXL) announced on Thursday its Anavex 2-73 Parkinson's treatment was successful in a preclinical study.

Anavex Life Sciences' Drug Shows Efficacy To Support Potential Disease Modification In Parkinson's Disease

Anavex Life Sciences' Drug Shows Efficacy To Support Potential Disease Modification In Parkinson's Disease

Michael J. Fox Foundation funded ANAVEX 2-73 drug candidate study presented at World Parkinson Congress 2016

Anavex To Participate In Mizuho Therapeutics Conference

Anavex To Participate In Mizuho Therapeutics Conference

Conference to Feature Companies with Focus on Alzheimer's, Parkinson's and other Neurological Diseases

Noteworthy Wednesday Option Activity: AVXL, CRUS, ASPS

Noteworthy Wednesday Option Activity: AVXL, CRUS, ASPS

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Anavex Life Sciences Corp , where a total volume of 10,707 contracts has been traded thus far today, a contract volume which is representative of approximately 1.1 million underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 90.4% of AVXL's average daily trading volume over the past month, of 1.2 million shares.